These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16753301)

  • 1. Short pseudopeptides containing turn scaffolds with high AT2 receptor affinity.
    Georgsson J; Rosenström U; Wallinder C; Beaudry H; Plouffe B; Lindeberg G; Botros M; Nyberg F; Karlén A; Gallo-Payet N; Hallberg A
    Bioorg Med Chem; 2006 Sep; 14(17):5963-72. PubMed ID: 16753301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity.
    Georgsson J; Sköld C; Plouffe B; Lindeberg G; Botros M; Larhed M; Nyberg F; Gallo-Payet N; Gogoll A; Karlén A; Hallberg A
    J Med Chem; 2005 Oct; 48(21):6620-31. PubMed ID: 16220978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and incorporation of a beta-turn mimetic in angiotensin II forming novel pseudopeptides with affinity for AT1 and AT2 receptors.
    Rosenström U; Sköld C; Lindeberg G; Botros M; Nyberg F; Karlén A; Hallberg A
    J Med Chem; 2006 Oct; 49(20):6133-7. PubMed ID: 17004728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New selective AT2 receptor ligands encompassing a gamma-turn mimetic replacing the amino acid residues 4-5 of angiotensin II act as agonists.
    Rosenström U; Sköld C; Plouffe B; Beaudry H; Lindeberg G; Botros M; Nyberg F; Wolf G; Karlén A; Gallo-Payet N; Hallberg A
    J Med Chem; 2005 Jun; 48(12):4009-24. PubMed ID: 15943474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of a new class of druglike angiotensin II C-terminal mimics with affinity for the AT2 receptor.
    Georgsson J; Sköld C; Botros M; Lindeberg G; Nyberg F; Karlén A; Hallberg A; Larhed M
    J Med Chem; 2007 Apr; 50(7):1711-5. PubMed ID: 17358051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and AT2 receptor-binding properties of angiotensin II analogues.
    Rosenström U; Sköld C; Lindeberg G; Botros M; Nyberg F; Hallberg A; Karlén A
    J Pept Res; 2004 Nov; 64(5):194-201. PubMed ID: 15485557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A selective AT2 receptor ligand with a gamma-turn-like mimetic replacing the amino acid residues 4-5 of angiotensin II.
    Rosenström U; Sköld C; Lindeberg G; Botros M; Nyberg F; Karlén A; Hallberg A
    J Med Chem; 2004 Feb; 47(4):859-70. PubMed ID: 14761188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling binding modes of angiotensin II and pseudopeptide analogues to the AT2 receptor.
    Sköld C; Nikiforovich G; Karlén A
    J Mol Graph Model; 2008 Feb; 26(6):991-1003. PubMed ID: 17936050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Phe308 in the seventh transmembrane domain of the AT2 receptor in ligand binding and signaling.
    Pulakat L; Mandavia CH; Gavini N
    Biochem Biophys Res Commun; 2004 Jul; 319(4):1138-43. PubMed ID: 15194486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological activities of four angiotensin II receptor ligands with gamma-turn mimetics replacing amino acid residues 3-5.
    Schmidt B; Lindman S; Tong W; Lindeberg G; Gogoll A; Lai Z; Thörnwall M; Synnergren B; Nilsson A; Welch CJ; Sohtell M; Westerlund C; Nyberg F; Karlén A; Hallberg A
    J Med Chem; 1997 Mar; 40(6):903-19. PubMed ID: 9083479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-dependent complex formation between the Angiotensin II receptor subtype AT2 and Na+/H+ exchanger NHE6 in mammalian cells.
    Pulakat L; Cooper S; Knowle D; Mandavia C; Bruhl S; Hetrick M; Gavini N
    Peptides; 2005 May; 26(5):863-73. PubMed ID: 15808917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Arg182 in the second extracellular loop of angiotensin II receptor AT2 in ligand binding.
    Kurfis J; Knowle D; Pulakat L
    Biochem Biophys Res Commun; 1999 Oct; 263(3):816-9. PubMed ID: 10512763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variety of angiotensin receptors in 3T3-L1 preadipose cells and differentiated adipocytes.
    Weiland F; Verspohl EJ
    Horm Metab Res; 2008 Nov; 40(11):760-6. PubMed ID: 18711690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective angiotensin II AT2 receptor agonists: arylbenzylimidazole structure-activity relationships.
    Wu X; Wan Y; Mahalingam AK; Murugaiah AM; Plouffe B; Botros M; Karlén A; Hallberg M; Gallo-Payet N; Alterman M
    J Med Chem; 2006 Nov; 49(24):7160-8. PubMed ID: 17125268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 angiotensin receptor (AT1-R)-mediated decrease in type 2 angiotensin receptor mRNA level is dependent on Gq and extracellular signal-regulated kinase 1//2 in AT1-R-transfected PC12 cells.
    Saito M; Shinohara Y; Sasaki H; Netsu Y; Yoshida M; Nakahata N
    J Neuroendocrinol; 2008 Mar; 20(3):299-308. PubMed ID: 18208547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II inhibitory peptide found in the receptor sequence using peptide array.
    Kato R; Kunimatsu M; Fujimoto S; Kobayashi T; Honda H
    Biochem Biophys Res Commun; 2004 Feb; 315(1):22-9. PubMed ID: 15013420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AT2-selective angiotensin II analogues containing tyrosine-functionalized 5,5-bicyclic thiazabicycloalkane dipeptide mimetics.
    Johannesson P; Erdélyi M; Lindeberg G; Frändberg PA; Nyberg F; Karlén A; Hallberg A
    J Med Chem; 2004 Nov; 47(24):6009-19. PubMed ID: 15537355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligands to the (IRAP)/AT4 receptor encompassing a 4-hydroxydiphenylmethane scaffold replacing Tyr2.
    Andersson H; Demaegdt H; Vauquelin G; Lindeberg G; Karlén A; Hallberg M
    Bioorg Med Chem; 2008 Jul; 16(14):6924-35. PubMed ID: 18556208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass-spectrometric identification of a novel angiotensin peptide in human plasma.
    Jankowski V; Vanholder R; van der Giet M; Tölle M; Karadogan S; Gobom J; Furkert J; Oksche A; Krause E; Tran TN; Tepel M; Schuchardt M; Schlüter H; Wiedon A; Beyermann M; Bader M; Todiras M; Zidek W; Jankowski J
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):297-302. PubMed ID: 17138938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.
    Cappelli A; Pericot Mohr Gl Gl; Gallelli A; Rizzo M; Anzini M; Vomero S; Mennuni L; Ferrari F; Makovec F; Menziani MC; De Benedetti PG; Giorgi G
    J Med Chem; 2004 May; 47(10):2574-86. PubMed ID: 15115399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.